Published: 2025-04-08
Status:
Analyzed
Predictions from this Video
Incorrect: 0
Prediction
Topic
Status
SRF's management expects strong revenue growth for Q4 FY25 and throughout FY26.
"The management expects further strong growth in quarter four of FY25 and FY26."
Pending
Domestic demand for R32 refrigerant is estimated to increase from 20,000 tonnes to 35,000 tonnes by 2028.
"Domestic demand for R32 is estimated to increase from 20,000 tonnes to 35,000 tonnes over the next three years. That is till 2028."
Pending
The price of R32 refrigerant is expected to increase further due to rising AC penetration and shorter replacement cycles.
"The price of R32 is expected to increase further due to increasing air conditioner penetration and shorter replacement cycle i.e. 3 to 5 years."
Pending
Favorable pricing for R32 and R22 refrigerants is expected to continue until 2025.
"This favorable pricing is expected to continue until 2025."
Pending
SRF's PTFE volumes are expected to increase in FY26.
"PTFE volumes are expected to increase in FY26."
Pending
The launch of new specialty chemical products by SRF will drive higher margins.
"Launch of new specialty chemical products will drive higher margins."
Pending
New active ingredients in SRF's specialty chemical segment will start making significant contributions from FY26 and may reach optimal utilization within 3-4 years.
"New active ingredients in the specialty segment will start making significant contributions from FY26 and may reach optimal utilization in the next three to four years."
Pending
SRF aims to capture 35-40% market share in the specialty chemical segment.
"SRF aims to capture 35 to 40% market share in this segment."
Pending
SRF plans to triple its pharmaceutical revenue within the next 3 years.
"SRF is collaborating with global innovators in pharmaceuticals and plans to triple its revenue in the next 3 years."
Pending
New product launches in SRF's fluorochemical segment are expected to drive strong growth in Europe and the US.
"The launch of new products in the fluorochemical segment is also expected to drive strong growth in Europe and the US."
Pending
SRF management expects chemical segment margins to reach 25%.
"management expects them to reach the guided range of 25%."
Pending
SRF plans capital expenditure of Rs 1500 crore in FY25 and Rs 1500-2000 crore in FY26.
"The company is going to do capex of Rs 1500 crore in FY25 and Rs 1500 to 2000 crore in FY26."
Pending
If the industry normalizes by FY27, SRF management plans to increase capex to Rs 2700-3000 crore.
"If the industry scenario normalises by FY27, the management plans to step up capex to Rs 2,700-3,000 crore."
Pending
SRF's new HFO plant (part of Rs 1100 crore capex) is planned to be operational by 2027.
"The new plan is planned to be operational by 2027."
Pending
SRF expects HFO exports to begin from FY28.
"Exports will start from financial year 28."
Pending
Domestic adoption of HFOs in India is expected after FY32.
"domestic adoption in India is expected after FY 32."
Pending
SRF's aluminium foil business is expected to improve, particularly if anti-dumping duty is imposed on Chinese imports.
"But improvement is expected in the aluminium foil business. Especially if anti-dumping duty is imposed on Chinese imports"
Pending
Citi estimates that a 7% US tariff on Indian chemical exports could reduce SRF's profitability by up to 4%.
"Citi estimates that if a 7% tariff is imposed, the impact on SRF could be up to 4%"
Pending
SRF management anticipates strong growth in Q4 FY25 and throughout FY26.
"The management expects further strong growth in quarter four of FY25 and FY26."
Pending
SRF's PTFE production volumes are expected to increase in FY26.
"PTFE volumes are expected to increase in FY26."
Pending
New active ingredients in SRF's specialty segment are projected to significantly contribute to revenue starting FY26 and reach optimal utilization in the next 3-4 years.
"New active ingredients in the specialty segment will start making significant contributions from FY26 and may reach optimal utilization in the next three to four years."
Pending
SRF targets capturing 35-40% market share in the specialty chemicals segment.
"SRF aims to capture 35 to 40% market share in this segment."
Pending
SRF plans to triple its revenue from pharmaceutical collaborations within the next 3 years.
"SRF... plans to triple its revenue in the next 3 years."
Pending
New fluorochemical products are expected to drive strong growth for SRF in Europe and the US.
"The launch of new products in the fluorochemical segment is also expected to drive strong growth in Europe and the US."
Pending
SRF management expects chemical segment margins to reach 25%.
"Margins in the chemical segment are improving and management expects them to reach the guided range of 25%."
Pending
SRF plans capital expenditure of ₹1500 crore in FY25 and ₹1500-2000 crore in FY26.
"The company is going to do capex of Rs 1500 crore in FY25 and Rs 1500 to 2000 crore in FY26."
Pending
If the industry normalizes by FY27, SRF management plans to increase capex to ₹2700-3000 crore.
"If the industry scenario normalises by FY27, the management plans to step up capex to Rs 2,700-3,000 crore."
Pending
SRF's new HFO plant is planned to be operational by 2027.
"The new plan is planned to be operational by 2027."
Pending
SRF's HFO exports are projected to begin in FY28.
"Exports will start from financial year 28."
Pending
SRF's aluminum foil business is expected to improve, particularly if anti-dumping duties are imposed on Chinese imports.
"But improvement is expected in the aluminium foil business. Especially if anti-dumping duty is imposed on Chinese imports,"
Pending
Citi estimates that a 7% US tariff on Indian chemical exports could impact SRF's profitability by up to 4%.
"Citi estimates that if a 7% tariff is imposed, the impact on SRF could be up to 4%,"
Pending
Domestic demand for R32 refrigerant is projected to increase from 20,000 to 35,000 tonnes by 2028.
"Domestic demand for R32 is estimated to increase from 20,000 tonnes to 35,000 tonnes over the next three years. That is till 2028."
Pending
R32 refrigerant price is expected to increase due to higher AC penetration and shorter replacement cycles.
"The price of R32 is expected to increase further due to increasing air conditioner penetration and shorter replacement cycle i.e. 3 to 5 years."
Pending
Favorable pricing for R32 and R22 refrigerants is expected to continue until the end of 2025.
"This favorable pricing is expected to continue until 2025."
Pending
Domestic adoption of HFOs in India is expected to commence after FY32.
"domestic adoption in India is expected after FY 32."
Pending